Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMUGENE LIMITED Director's Dealing 2021

May 26, 2021

65124_rns_2021-05-26_a08cd1d7-b266-4ee1-b2e5-6b93e99fa3dc.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001. Amended 01/01/11

Name of Entity: Imugene Limited (ASX:IMU)
ACN: 009 179 551

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Paul Hopper
Date of Last Notice: 23 Dec 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

director” should be disclosed in this part.
Direct or Indirect Interest Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest. Director related entity
Date of change 25 May 2021 to 26 May 2021
No. of securities held prior to change
Shares Options
Direct 1,248,900 -
Indirect 176,716,568 25,000,000
Total 177,965,468 25,000,000
Class Fully Paid Ordinary Shares (IMU) and UnlistedOptions
Number acquired
Shares Options
Direct - -
Indirect a) 25,000,000 -
**Total ** 25,000,000 -
Number disposed
Shares Options
Direct - -
Indirect b) 1,500,000* a) 25,000,000
Total 1,500,000* 25,000,000
*Indirect Interest (Deborah Coleman)
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote:If consideration is non-cash, provide details and estimatedvaluation a) between $0.040 and $0.045 per shareb) $702,339 a) between $0.040 and $0.045 per shareb) $702,339 a) between $0.040 and $0.045 per shareb) $702,339
No. of securities held after change Options---
Shares Options
Direct 1,248,900 -
Indirect 200,216,568 -
**Total ** 201,465,468 -
Nature of changeExample:on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back a) Exercise of Options.b) On-Market Trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

director” should be disclosed in this part.
Detail of contract N/A
Nature of interest N/A
Name of registered holder(if issued securities) N/A
Date of change N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed N/A
Interest acquired N/A
Interest disposed N/A
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation N/A
Interest after change N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 – Closed period

Were the interests in the securities or No contracts detailed above traded during a +closed period where prior written clearance was required? If so, was prior written clearance N/A provided to allow the trade to proceed during this period? If prior written clearance was N/A provided, on what date was this provided?

==> picture [39 x 23] intentionally omitted <==

The CFO Solution

  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3